Clinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

dc.contributor.authorMönkäre Saana
dc.contributor.authorKuuluvainen Liina
dc.contributor.authorSchleutker Johanna
dc.contributor.authorMyllykangas Liisa
dc.contributor.authorPöyhönen Minna
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code2607100
dc.converis.publication-id176538135
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/176538135
dc.date.accessioned2022-11-29T14:56:30Z
dc.date.available2022-11-29T14:56:30Z
dc.description.abstract<p><strong>Objectives: </strong>Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a cerebral small vessel disease caused by pathogenic variants in the NOTCH3 gene. In Finland, the majority of CADASIL patients carry the pathogenic founder variant c.397C>T, (p.Arg133Cys), but the spectrum of other NOTCH3 variants has not been investigated previously. The aim of the study was to investigate the spectrum and prevalence of NOTCH3 variants Finnish CADASIL patients and to examine the clinical features associated with them.</p><p><strong>Materials and methods: </strong>The spectrum of NOTCH3 variants and the clinical features associated with them were retrospectively examined in 294 Finnish CADASIL patients tested during January 1996 to October 2021 in the Medical Genetics laboratory of Department of Genomics of Turku University Hospital, where practically all samples of patients with suspected CADASIL in Finland are investigated.</p><p><strong>Results: </strong>The most common NOTCH3 variants in the study cohort were c.397C>T, (p.Arg133Cys) (68%) and c.3206A>G p.(Tyr1069Cys) (18%), but other less common NOTCH3 variants were detected in as many as 14% of the patients. Eight of the detected NOTCH3 variants were novel: c.520T>A,p.(Cys174Ser), c.836A>G,p.(Gln279Arg), c.1369T>G,p.(Cys457Gly), c.1338C>G,p.(Cys446Trp), c.1564T>G,p.(Cys522Gly), c.2848T>G,p.(Cys950Gly), c.6102dup,p.(Gly2035Argfs*60), and c.2410+6C>G. Other NOTCH3 variants than p.Arg133Cys and p.Tyr1069Cys were more often associated with more severe clinical features.</p><p><strong>Conclusion: </strong>This study revealed the genetic and clinical spectrum of CADASIL in the Finnish population. Sequencing of the whole NOTCH3 gene performing a gene-panel or exome sequencing is recommended when suspecting CADASIL.</p>
dc.format.pagerange351
dc.format.pagerange643
dc.identifier.jour-issn0001-6314
dc.identifier.olddbid190036
dc.identifier.oldhandle10024/173127
dc.identifier.urihttps://www.utupub.fi/handle/11111/30714
dc.identifier.urnURN:NBN:fi-fe2022110164040
dc.language.isoen
dc.okm.affiliatedauthorMönkäre, Saana
dc.okm.affiliatedauthorSchleutker, Johanna
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWILEY
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1111/ane.13703
dc.relation.ispartofjournalActa Neurologica Scandinavica
dc.relation.issue5
dc.relation.volume146
dc.source.identifierhttps://www.utupub.fi/handle/10024/173127
dc.titleClinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Acta Neuro Scandinavica - 2022 - M nk re - Clinical features and spectrum of NOTCH3 variants in Finnish patients with.pdf
Size:
677.08 KB
Format:
Adobe Portable Document Format